DIVI S LABORATORIES LTD vs HEALTH X PLATFORM LIMITED

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and HEALTH X PLATFORM LIMITED (HEALTHX) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs HEALTHX on 11 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
858.38
10.72
P/B ratio
1.57
0.44%
Dividend yield
0.00%
₹96.73
EPS
₹0.37

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
0.29%
22.00%
Return on capital
-4.88%
33.00%
EBITDA margin
-4.00%
24.32%
Net margin
-0.08%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
7.56%
12.10%
Profit CAGR (3Y)

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹1,025 Cr
₹10,560 Cr
Revenue
₹1,319 Cr
₹2,568 Cr
Net profit
₹-1 Cr
0.00
Debt / equity
0.00
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
HEALTH X PLATFORM LIMITED
  • + ["Company is almost debt free.", "Company's median sales growth is 36.1% of last 10 years", "Company's working capital requirements have reduced from 40.4 days to 16.0 days"]
  • ["Company has low interest coverage ratio.", "Company has a low return on equity of 2.06% over last 3 years.", "Earnings include an other income of Rs.57.1 Cr."]
DIVI S LABORATORIES LTD full analysis HEALTH X PLATFORM LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.